Cephalon, Inc.Malvern, PA United States
Company Description
Cephalon has a cabinet stocked with specialty drugs. The company's research, development, manufacturing, and marketing activities focus on therapies for central nervous system (CNS) disorders, cancer, pain, and inflammatory disease. Its NUVIGIL and PROVIGIL drugs treat the sleep disorder narcolepsy. The company's other top sellers are cancer drug TREANDA, cancer pain medications ACTIQ and FENTORA, epilepsy treatment GABITRIL, and muscle relaxant AMRIX. It also markets some generic pharmaceuticals. While the firm's products are primarily sold in the US and Europe, its medicines are available in some 100 countries. Cephalon was acquired by top generic drugmaker
| 41 Moores Rd. | Phone: 610-344-0200 | http://www.cephalon.com |
| Malvern, PA 19355 | 
Map This Company | |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Cephalon, Inc. Rankings
| #690 in FORTUNE 1000 (May 2011) |
Executives
| 104 executives listed for Cephalon, Inc.'s Malvern, PA location. | ||
| Chairman | William Egan | |
|---|---|---|
| CEO and Director | J. Kevin Buchi | |
| EVP and Chief Scientific Officer | JeffryVaught | |
Financials
| Company Type | Subsidiary - NASDAQ: CEPH Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 3,726 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Cephalon, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
